Aberrant sphingolipid signaling is involved in the resistance of prostate cancer cell lines to chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/10582708

Cancer Res. 1999 Nov 15 59 22 5842-8

Download in:

View as

General Info

PMID
10582708